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In tuberculosis, the obvious, known as empiricism, has fre-
quently been correct in generalities; but painstaking, scienti-
fically controlled investigation becomes necessary to disclose the
finer mechanisms and to clarify facts, the explanation of which has
bordered at times on no more than mere speculation. Again, faulty
methods may lead to faulty deductions or to deductions which are
worthless because they are based on faulty premises or tests. In
point, a statement made in 1942 in an article entitled "Immunity
in Tuberculosis,"16 evidently based on good reasoning and certain
literature, states "The action of living bacilli in creating immunity
and stimulating healing may be initiated by dead bacilli. Bacillary
proteins (tuberculin) are recognized as the active factors in produc-
ing these effects. Tuberculin will not produce all of the reactions
of the tubercle bacillus, but when used therapeutically will produce
many of the effects which are necessary to healing. It has a logical
basis for use, though it is not a perfect immunizing agent." Yet
not one point of these statements is borne out by scientific evidence.
The earliest controlled experimental data on the significance of
specific immunity in tuberculosis were obtained by Robert Koch, who
accurately described the changes in animals consequent to such
immunity. Then followed the confusion incident to tuberculin, its
multiple forms, and exploitations as a therapeutic agent. By 1912,
Paul Roemer defined specific immunity in animal experiment more
accurately. He noted that the injection of dead bacilli did not pro-
duce it, but he believed the tuberculin hypersensitive reaction was
responsible for its production in some way. This latter view was
expressed also by Allen Krause and his colleagues on the basis of
extensive experiments from 1920 to 1926, and Calmette did not
present any evidence in his exhaustive studies with BCG to refute
such a view.2 In 1936, as a result of the study of the behavior of
tubercle bacilli within the body,'0 evidence was presented to verify
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the existence of a beneficial specific immunity in tuberculosis and
its production by means of viable avirulent tubercde bailli but not
by heat-killed tubercle bacilli. Viable avirulent human or bovine
(BCG) tuberde bacilli did not produce progressive lesions in man
but lost their viability. The reactions to viable avirulent tubercle
bacilli in man and animals show a sequence of changes upon repeated
injeCtionS.11' 14 In 1939, it was recorded that specific immunity
against infections with virulent human tubercle bacilli could not be
produced by Seitz filtrates from cultures of virulent human tuberde
bacilli, by highly concentrated (ultradialysis) filtrates, or by the
precipitated tuberculoprotein or alum-treated filtrate. The highly
concentrated filtrates, or precipitated tuberculoprotein, possess no
appreciable primary toxicity for normal animals. However, they
do sensitize anaphylactically. The production of cutaneous hyper-
sensitiveness to tuberculoprotein requires a small amount of aviru-
lent tuberde bacilli, a large amount (100 mg.) of heat-killed
tuberde bacilli, and a very small amount of virulent tuberde bacilli
(multiplication and tuberculous involvement being factors with the
latter).
In 1940,5 it was pointed out that after a proper incubation period
tuberculous and bacillary injected animals given injections of filtrate
do not die in anaphylactic shock but die protractedly from allergic
intoxication. The two reactions, anaphylactic and allergic, were
demonstrated to co-exist in the same animal. It appeared then
that specific anaphylaxis plays no significant role in experimental
tuberculosis, while the intoxication was closely related to specific
allergy, whether due to tuberculin or bacillary body was not dear.
It was further noted3 that the bacillary body sensitizes primarily to
tuberculo-allergy and serves to immunize against virulent infection,
while the natural filtrate containing tuberculoprotein sensitizes to
anaphylaxis and provokes anaphylactic shock and allergic intoxica-
tion, but does not sensitize to allergy nor specifically immunize
againstvirulentinfection. Tuberculo-anaphylaxis, tuberculo-allergy,
and tuberculo-immunity show distinctive characteristics which led
to the conclusion that they are separate and apparently unrelated
biologic phenomena. The skin reaction (allergic) may be absent
entirely in guinea-pigs which still retain their specific tuberculosis
immunity.12 Desensitization with filtrate (tuberculoprotein) to the
skin (tuberculin) reaction exerts no influence upon the specific tuber-
culosis immunity. In 1941, it was noted1" that the specific toxicity
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of tuberculosis cannot yet be definitely stated, because we lack
information regarding the part played by the products of tuberde
bacilli liberated in vitro (natural filtrate containing tuberculoprotein-
tuberculin9) but apparently not liberated in appreciable amounts
in vivo. Desensitization with these products presents a fascinating
problem. The evidence obtained would seem to question whether
the active constituent of in vitro natural filtrate from the growth
of tubercle bacilli is liberated in vivo. In spite of this, desen-
sitization of bacillary tuberculo-allergically sensitized animals
(prepared with either avirulent or virulent human tuberde bacilli)
can be accomplished by appropriate treatment with natural tuber-
cul-filtrate (tuberculoprotein-tuberculin) when it is used in rela-
tively small, primarily non-toxic, amounts. Under these conditions,
animals thus prepared do not show a local specific skin reaction to
tuberculin and are likewise protected against a lethal general tuber-
culo-allergic shock intoxication. This protection can be transferred
to a tuberculo-allergic sensitive animal with the blood from a desen-
sitized tuberculo-allergic animal. Tuberculo-desensitization with
primarily non-toxic amounts of tuberculoprotein exerts no beneficial
or detrimental effect upon tuberculosis or upon specific tuberculosis
immunity. However, recognizing the fact that practically all evi-
dence indicates that tuberculin plays no part in natural tuberculosis
and that apparently it is not liberated in vivo (in contrast to the in
vitro findings), it would seem highly desirable to note further how
the phenomena with tuberculin, such as tuberculin allergic immuni-
zation (desensitization) and tuberculin allergic intoxication, may
come into the picture of tuberculosis which appears practically to be
closely bound up, not with tuberculin allergic effects, but rather with
tuberculo-bacillary allergic effects.
Present investigations
Effects of tuberculin treatment on tuberculosis.
Since more recent observations' on the effects of tuberculin on
tuberculosis indicated that appropriate tuberculin desensitization
against tuberculo-allergic intoxication could protect against the
immediate results of the intravenous injection of large infecting
amounts of virulent tubercle bacilli and could, therefore, under
suitable experimental conditions, prolong the life of specific tuber-
culo-immune guinea-pigs following the intravenous injection of
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virulent tuberci.e bacilli, it was deemed advisable to follow these
studies by noting the effects of tuberculin treatment after the use
of smaller infecting doses of bacilli. This would result in making
possible a more prolonged treatment with smaller amounts of
tuberculin and, in consequence of the smaller infecting injections
of bacilli, result in the development of a more protracted and less
violent, but still progressive, chronic type of tuberculosis in the
animals. In all interpretations of the effect of tuberculin it must
be remembered, as was pointed out previously,12 that the toxicity
of tuberculin (tuberculoprotein containing filtrate from culturing
tuberde bacilli) both generally and locally is contingent upon the
tuberculo-allergic hypersensitiveness. In the tuberculous animal
this strikingly parallels the amount of tuberculous involvement and,
more or less directly, the progressiveness of the tuberculous disease
and infection when the latter is due to highly virulent bacilli. For
this reason continued relatively large injections of tuberculin, readily
tolerated by subcutaneous injection in the early periods of infection,
may prove lethally toxic in later injections. The entire problem
of suitable amounts to be used even experimentally therefore must
always remain in flux. However, in order to note the effect of
tuberculin treatment on various infecting amounts of virulent human
tuberde bacilli in guinea-pigs, the amount was kept constant in
the following experiments because the variation in the tuberculosis
could be controlled more readily than, any attempt at varying the
dosage of tuberculin. In the following experiment, the infecting
amounts of virulent human tuberde bacilli (H 160) were given
intravenously in amounts of 1 mg., 0.001 mg., and 0.000,001 mg.;
and in the treated animals, tuberculin was given subcutaneously
twice weekly (begun coincident with infection) in amounts of 0.5 cc.
of natural Seitz filtrate obtained from Wong Weinzirl medium
cultures of tubercle bacilli, each cubic centimeter containing about
0.6 mg. of tuberculoprotein (Seibert).' The intravenous (ear vein)
route of infection was used to assure a better immediate general
distribution of the infection. Thus the influence of specific immun-
ity on the tuberculous involvement was avoided, which might be
more evident following local, subcutaneous infections especially with
small infecting amounts of tubercle bacilli. The results of this
part of the study are recorded in Table 1.
It is evident from the results recorded in Table I that tuber-
culin given to infected guinea-pigs, begun with infection and in
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TABLE 1
THE EFFECT OF TUBERCULIN ON INFECTION WITH VIRULENT TUBERCLE BACILLI
Amount of virulent huma Survival
tubercle bacilli used for intrave- after Amount of Average svival
nou* infection and tuberculin infection tuberculous afterinfection
treatment in days involvement in days
22 Acute generalt
1 mg. .......................................... 28
CC CC 26
29
17 CC sC
1 mg. treated ....................... 20 " 's 19
21
cc cc
42 3
0.001 mg . ....................... 5 4 55
67 4
57 3
0.001 mg. treated ....................... 60 4 67
83 4
162 4
0.000,001 mg.176 4 181
204 4
129 3
0.000,001 mg. treated .130 3 148
186 4
*A virulent strain of-human tubercle bacilli was used for intravenous infection.
tThese guinea-pigs usually died too early to present gross tuberculous lesions,
and the microscopic sections of the organs presented multiple small foci. The
grading of the macroscopic organic tuberculosis is recorded in numerals from I to 4,
indicating a slight involvement (1) to a massive generalized disease (4) of all
important organs.
relatively large therapeutic dose, may prove sufficiently toxic when
given to heavily (1 mg.) intravenously infected guinea-pigs to
shorten the life span- from an average of 26 to 19 days. On the
other hand, when the infecting dose is reduced (0.001 mg.), result-
ing in a longer life span and more retarded lethal infection, the life
span of the tuberculin treated guinea-pigs may exceed that of the
untreated average of 67 days compared to 55 days. However, when
the infection is less progressive, resulting from a 0.000,001 mg.
intravenous infecting dose, the large therapeutic dose of tuberculin
and its prolonged use in the presence of the gradually evolvingYALE JOURNAL OF BIOLOGY AND MEDICINE
organic tuberculosis again results in a shortened life expectancy,
from an average of 181 days in the untreated to 148 days in the
tuberculin treated animals.
In an earlier report, it was noted that the life of specific immune
and intravenously heavily infected guinea-pigs was prolonged by
appropriate tuberculin treatment, and the part played by tuber-
culous allergic intoxication in this was observed. In view of these
findings, it was felt that tuberculin treatment should also be tried
on a series including not only specific immune guinea-pigs but
also infected guinea-pigs not previously immunized as controls and
sirnilar guinea-pigs not deliberately immunized but treated with
tuberculin. The intravenous infecting dose should also be suffi-
ciently large (0.01 mg.) to exclude the possibility of the develop-
ment of a specific tuberculo-immunity which would interfere with
interpretation and such as might possibly develop naturally after
one or two months in a slowly progressive disease.
Such an experiment is illustrated in Chart 1, which expresses the
results obtained with four different groups of guinea-pigs.
Group 1. Infection controls; each received intravenously 0.01 mg. of vir-
ulent human tubercle bacilli (H 160) in fine suspension.
Group 2. Guinea-pigs similarly infected; treated twice weeldy by subcuta-
neous injection of 0.5 cc. of natural Seitz filtrate (tuberculin);
tuberculin treatment initiated 1 month prior to infection and con-
tinued throughout the life of the animals.
Group 3. Guinea-pigs vaccinated with I mg. of avirulent human tubercle
bacilli; material given subcutaneously 1 month prior to an intra-
venous infection similar to that given group 1.
Group 4. Treatment similar to that given group 3; also given subcutaneously
0.5 cc. of natural filtrate (tuberculin) twice weekly; initiated
at the time of vaccination and continued throughout the experiment
to prevent the development of allergic tuberculin hypersensitiveness
due to the vaccinating injection and, later, the virulent infection.
The duration of life of the infection controls (group 1) was
38, 41, 44, 45, 46, and 57 days, averaging 45 days; of the virulent
infected and tuberculin treated (group 2) the duration of life was
38, 41, 48, 49, 52, and 57 days, averaging 47 days; of the specific
immune (vaccinated) guinea-pigs, the duration of life was 48, 50,
69, 87, 87, 101, and 101 days, averaging 77 days; and the specific
immune and tuberculin treated guinea-pigs lived 41, 55, 60, 83, 91,
119, and 147 days, averaging 85 days. Chart 1 presents graphically
the survival time and weight curve of the individual guinea-pigs in
this experiment. It is to be noted that the tuberculin treated and
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vaccinated guinea-pigs gained weight normally before virulent
infection, indicating the absence of any appreciable detrimental
effect of these procedures themselves on the animals.
An examination of Chart 1 suggests that with this virulent
CHART 1
The effect of continued tuberculin desensitization (immunization) on the dura-
tion of life of tuberculous guinea-pigs and specific tuberculo-immune guinea-pigs.
Specific tuberculo-immunization and tuberculin allergic immunization (desensitiza-
tion) were initiated beginning with the weight curve; infection, "INF", was by the
intravenous injection of 0.01 mg. of virulent tubercle bacilli 29 days later; and death
is indicated by the termination of the weight curve. Note prolongation of life of
specific immune animals over "controls" and "tuberculin treated."
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infecting dose (0.01 mg.) the tuberculin treatment exerts no appre-
ciable beneficial or detrimental effect on the virulent intravenous
infection; but that while specific immunization prolongs the
average life of the guinea-pigs from 45 to 77 days, it is further
prolonged, though not strikingly, by the tuberculin treatment, from
77 to 85 days, with this dosage. This verified the findings pre-
viously recorded and encouraged further extension of the experi-
ment to note whether it could be explained and whether it was
consistent with smaller infections in immune animals. In evaluat-
ing these experiments, it must be recognized further that tuberculin
treatment exerts no specific beneficial effects upon experimental
tuberculosis developing either in normal or specifically immunized
animals.
The following Chart 2 shows the results of another experiment
which duplicated the foregoing in all details except that the virulent
intravenous infection was replaced by subcutaneous infection with
0.000,1 mg. of virulent human tubercle bacilli (H 160). This
type of infection usually leads to a more slowly progressive meta-
static disease in the guinea-pig, with a decidedly increased survival
period both in normal infected and immune infected animals.7
The duration of life and amount of organic tuberculosis of the
infection controls (group 1) were 53 days (4+ tuberculosis), 95
days (4+), 123 days (4+), 125 days (4+), 167 days (4+), and
186 days (4+), averaging 125 days; of the virulent infected and
tuberculin treated group 2, life duration was 43 (4+), 61 (4+),
68 (4+), 79 (4+), 139 (4+), and 160 (4+), averaging 91 days;
of the specific immune (vaccinated) guinea-pigs, it was 212 (3+),
212 (4+), 242 (4+), 261 (4+), 266 (4+), averaging 238 days
(1 guinea-pig died from apparent extraneous causes free from
organic tuberculosis on the 88th day); and of the specific immune
and tuberculin treated guinea-pigs, duration of life was 180 (3+),
181 (3+), 230 (4+), and 250 (4+), averaging 210 days (2
guinea-pigs died from apparent extraneous causes free from tuber-
culosis on the 95th and 159th days, respectively.)
Contrary to the findings recorded in Chart 1, where there was
either no effect of tuberculin treatment or a slight beneficial effect
on the life span, the prolonged use of the tuberculin as maintained
in this experiment with smaller infecting dose and -resultant less
progressive disease exerted a detrimental effect on the life duration.
This is evident from the average reduction of life from 125 to 91
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days in the infected as compared with the infected treated amals,
and the average reduction oflife from 238 to 210 days in thespecific
(vaccinated) immune as compared with the immune infected and
tuberculin treated guinea-pigs.
These apparent incongruous findings, for which we have no
other explanation than that of a possible effect of tuberculin intoxi-
cation versus tuberculin desensitization or allergic immunization,
may explain the divergent results reported by Willis and others,18
using excessive amounts of tuberculin (usually 0.1 mg.) with con--
sequent detrimental effect, and those more recently reported by
Birkhaug,l who used smaller amounts of tuberculin and noted a
beneficial effect of tuberculin desensitization (Iathergic-G. iathein,
to be healed, and energeia, force-immunity to tuberculosis) on
immune vaccinated (killed BCG in solid paraffin) animals. It also
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CHART2
The effect of continued tuberculin desensitization (immunization) on the dura-
tion of life of tuberculous guinea-pigs and specific tuberculo-immune guinea-pigs.
Specific tuberculo-immunization and tuberculin allergic immunization (desensitiza-
tion) were initiated beginning wi-th the weight curve; infection, "INF", was by the
subcutaneous injection of 0.000,1 mg. of virulent tubercie bacilli 31 days later;
and death is ind'icated by the termination of the weight curve. Dotted-line weight
curve indicates that these animals died of causes other than tuberculosis. Note pro-
longation of life ofspecific immune animals over "controls" and "tuberculin treated,"
and of the "specific immune" over the "specific immune and tuberculin treated."
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explains why some observers in the past were unable to note any
effect from the use of tuberculin either in infected or immunized
infected animals"3 when experimentation was limited in extent. One
of the important difficulties encountered is the use of organisms
about which little is known. Unsatisfactory quantitation is also a
difficulty. Improperly biologically evaluated tuberde bacilli should
never be used for exact comparative studies. This preliminary
evaluation is as essential to proper interpretation as is the use of
pure chemicals by the chemical investigator. The narrow latitude
of beneficial tuberculin effect which remains unexplained today
and the equally dangerous detrimental counter-effect have led
to the conclusion that tuberculin cannot be relied upon either as a
desensitizing agent or as a focal stimulating reagent. As will be
shown later, the immunization or desensitization is only against
tuberculin, which apparently is not liberated in vivo, and not against
the bacillary factor which appears practically to be most important.
When used as a focal stimulating reagent, tuberculin may prove
extremely dangerous because of the unknown factors playing a
part in possible intoxication, such as the tuberculous involvement
and the tuberculo-allergic hypersensitiveness. As gratifying as have
been the positive results from investigations on specific tuberculo-
immunization with avirulent tuberdle bacilli and from the analysis
of the reactions by infection, allergic, and anaphylactic tests, just so
fruitless have been the studies with tuberculin, which apparently is
only an in vitro product oftuberde bacilli not involved in the natural
processes associated with infection and which has no definite dis-
tinguishable value for the immunization treatment of tuberculosis
per se or tuberculous allergic hypersensitiveness. This may explain
both the pro and con extensive literature on tuberculin therapy, an
intricate problem offering no decisive solution.
The effect of the tuberculin (allergic) reaction on the development
of tuberculosis
In view of the foregoing results and the indecisiveness of the
tuberculin treatment findings in tuberculosis, it appeared desirable
to study further, in tuberculo-allergic hypersensitive animals, the
local effects of tuberculin reactions on (a) the reaction to the
tubercle bacilli at the sites of such local reactions, and (b) the subse-
quent fate of the bacilli in so far as this could be determined from
the resulting generalized disease in the animals. In order to elimi-
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nate as far as possible the specific immunity effects, tuberculo-allergic
hypersensitiveness was produced in guinea-pigs by injecting killed
tuberde bacilli suspended in mineral oil.8
After failing to induce a satisfactory tuberculin-like inflammation
by other means, Krause and Willis'" in 1920 resorted to the inocu-
lation of living tuberde bacilli into areas of the skin which were
undergoing various stages of the tuberculin reaction. They were
obliged to work with tuberculous animals at that time, but a certain
comparison was possible by using the normal non-reacting skin of
similarly re-infected guinea-pigs for comparison. Their deductions
were as follows: both allergy and immunity were reduced at the
site of an inflammatorytuberculin reaction for at least four days after
the application of tuberculin; they were more reduced by inflam-
matory tuberculin reactions at places which are within the lymphatic
drainage area of tuberculous foci than at places which are not so
situated; they are reduced to a greater extent shortly (one or two
days) after the application of tuberculin than at a later time (four
days after tuberculin). They concluded that "the part played by
the inflammation of the allergic reaction considered purely by itself,
remains undisclosed." Although the experiment was crudely per-
formed, and used bacilli with properties poorly defined, this work,
when viewed in the light of the period, represented a notable
advance, particularly since this problem has not been studied any
moreeffectively since thattime. They lacked, however, the modern
knowledge on the virulence of tubercle bacilli, specific tuberculo-
immunity, and the ability to quantitate their experiments to discern
better the various ramifications of the interacting relations. In the
following recorded experiments, and in other preliminary tests not
recorded here, these have been supplied.
In the following experiment on the effect of the local allergic
reaction on tuberculosis, three groups of animals were included:
Group 1. Control normal guinea-pigs.
Group 2. Tuberculo-allergic hypersensitive animals prepared by the sub-
cutaneous injection of 1 mg. of heat-killed avirulent human tubercle
bacilli suspended in 1 cc. of light mineral oil.
Group 3. Specific tuberculo-immune and tuberculo-allergic hypersensitive
animals prepared by the subcutaneous injection of 1 mg. of viable
avirulent human tubercle bacilli.
The tuberculo-allergic hypersensitive animals (groups 2 and 3) were
divided into 4 sub-groups each comprised of 3 guinea-pigs, as follows:
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(a) These were not injected intracutaneously with tuberculin.
(b) These animals received tuberculin (0.1 cc. containing 0.0005 mg.
of tuberculoprotein Seitz filtrate) mixed with the bacilli and injected intra-
cutaneously.
(c) These animals were injected intracutaneously with tuberculin 24
hours before bacilli were injected, also intracutancously, into the tuberculin
site.
(d) In these animals the interval between the intracutaneous injection
of tuberculin and of bacilli was 48 hours instead of 24 hours as in (c).
Each guinea-pig in the three groups (1, 2, and 3) was injected
intracutaneously as outlined in a, b, c, and d, so that in duplicate
on each side of the midline on the ventral side 3 different amounts of
virulent human tuberde bacilli (H 160) were injected. The actual
amounts of bacilli injected were 0.001 mg., 0.000,01 mg., and
0.000,000,1 mg. Careful readings of the local lesions were
recorded by photographing the animals under the same conditions of
magnification, etc., and the glandular readings were recorded by
approximate palpation measurement. Sixty-one days after virulent
infection, the animals were sacrificed and the amount of generalized
tuberculosis was noted.
Since the major findings in this experiment can be summarized
by taking note of the most pertinent intervals and illustrating these
by selected photographs rather than by tabulating the detailed
measurements of the lesions, this method is chosen here. Figures
1 to 8 portray the changes noted in each set at periods of 2 days,
1, 2, 4, and 8 weeks, and in the internal organs at postmortem
61 days after the multiple intracutaneous infections. The skin
photographs were all taken at the same magnification so that com-
parative sizes are presented. The pertinent findings were: (a) the
skin sites in the control animals (only infected intracutaneously,
Fig. 1) showednoappreciablevisible lesionswith any ofthe amounts
of the virulent tubercie bacilli until the second week, after which the
reactions in all sites rapidly progressed; (b) the sites in the allergic
(oil-heated sensitized, Fig. 2) andin thespecfic allergic andimmune
(vaccinated with viable avirulent bacilli, Fig. 5) guinea-pigs devel-
oped to the larger amount of baclli (0.001 mg.) an immediate
reaction and a nodule which persisted and progressed only compara-
tively slowly. In the latter two groups, it is noteworthy that while
thelesions to the §maller amounts of baclli progressed in the specific
allergic animals (Fig. 2), no such progression was noticeable in the
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specific allergic and immune animals (Fig. 5). These same effects
reflected as presence or absence of adenopathy were indicated in the
tributary glands, axillary and inguinal, draining the multiple skin
lesions. The postmortem findings also reflect this effect in that
there was no internal organic tuberculosis in the specific allergic
immune guinea-pigs while the specific allergic guinea-pigs revealed
definite splenic involvement though perceptibly less than the control
animals.
A comparison of the lesions which developed in the tuberculin
site when tuberculin was injected coincidently with the bacilli or
when injected into the site of the tuberculin reaction after 24 or 48
hours shows that the coincident injection results in a slightly more
progressive local lesion than when the bacilli are injected 24 or 48
hours later. After 48 hours, there appears to be an appreciable
retardation in the local lesion. However, the internal tuberculosis
is appreciably augmented if bacilli are injected 24 hours (a greater
effect occurs when the interval is 48 hours) or more after the
tuberculin has been injected; this was noticeable both in the specific
allergic and specific allergic and immune guinea-pigs. In view of
the fact that these results appeared complicated by the multiple
intracutaneous injections and lesions, it seemed desirable to note
further whether these findings would be borne out in the case of a
single injection. In order to note this, the foregoing experiment
was practically duplicated, but only a single intracutaneous injection
(0.01 mg.) of virulent human tubercle bacilli (H 160) was given
and, in addition, the effect of tuberculin immunization (desensitiza-
tion) against the specific allergy was observed in two additional sets
of guinea-pigs-the specific allergic, and the specific allergic and
immune animals. The larger amount (0.01 mg.) used for the
bacillary intracutaneous injection was chosen because this is a tuber-
cle-forming amount of bacilli for a normal guinea-pig.
The findings disclosed that essentially it made little difference
whether multiple intracutaneous injections ofvirulent tuberde bacilli
were given or a single large injection (above the threshold of tuber-
cle formation) was used so far as the specific allergic condition or
the specific allergic and immune condition was reflected in the
effect of the local tuberculin injection upon the reaction to the
bacilli. While the skin lesion developed earlier in the specific
allergic and specific allergic and immune guinea-pigs, it was decid-
edly less progressive even with this large dose as compared with
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the lesion in the normal guinea-pigs, a lesion which appeared later
and progressed more rapidly after its appearance. However, the
significant and striking feature of this experiment was the fact (as
shown in Fig. 9) that while tuberculin desensitization or immuniza-
tion against the specific allergic tuberculin reaction abolished the
local effect to tuberculin in both the specific allergic sensitized
(heated bacilli in oil) and thespecific allergic and immune vaccinated
(with viable avirulent tuberde bacilli) guinea-pigs, it did not abolish
the accentuated specific allergic bacillary hypersensitiveness, since
the reactions to the bacilli were no different in the tuberculin desen-
sitized animals than they were in the animals not desensitized (or
immunized) against tuberculin. The tuberculin injected for desen-
sitization was given intravenously every 5 days for 7 injections,
using 0.1 cc. of a natural Seitz filtrate containing 0.07 mg. tuberculo-
protein,18 and initiated at time of injection of the oil or avirulent
bacilli. Because of the large amount of virulent bacilli used intra-
cutaneously in single injection, the effects of local tuberculin injec-
tion coincident, and 24- and 48 hours prior to the injection of the
bacilli were not as evident, though they corroborated the findings
previously noted. However, the findings in the internal organs are
presented in Figs. 10 and 11, and theystrikingly confirm those noted
in the organs following the multiple intracutaneous injections. In
comparison with the findings 53 days after injection of the virulent
tubercle bacilli (0.01 mg. H 160) in the control animal infected
only intracutaneously and revealing a well-marked splenic tuber-
culosis (with multiple large discrete tuberdes), the specific allergic
(dead tubercle bacilli in oil) guinea-pigs (Fig. 10) revealed no
appreciable splenic tuberculosis regardless of whether they were
or were not desensitized by means of tuberculin (tuberculoprotein).
However, when the non-desensitized animals were injected intra-
cutaneously coincident with tuberculin locally, an absence of splenic
and organic tuberculosis was noted, but if the tuberculin site had
existed for 24 or 48 hours, splenic and organic involvement again
became evident, as in the previous experiment with multiple skin
injections. In the case of the specific tuberculo-immune animals
(vaccinated with viable avirulent bacilli), the same findings were
obtained though they were less evident because of the effect of the
combined allergic and immune phenomena (Fig. 11). While the
organs, including the spleen, were free from tuberculosis in both
the non-desensitized and tuberculin desensitized specific immune
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animals, the injection of the bacilli coincidently with the tuberculin
intracutaneously did not change this; but when the bacilli were
injected 24 or 48 hours after the local tuberculin injection and into
the reacting site, a small amount of splenic involvement became
evident (Fig. I 1). The -amount of tuberculin used locally in the
skin (0.1 cc. of a 1:100 dilution of natural Seitz filtrate = 0.0007
mg. tuberculoprotein) wasenough toproduce a definite erythematous
edematous reaction of about 1 to 2 cm. in diameter in a guinea-pig
which had received 1 mg. of viable avirulent human tubercle bacilli
subcutaneously from 1 to 3 months prior to the tuberculin test, and
enough to cause a definitely more intense reaction, with necrosis at
times, in a guinea-pig with specific allergy (caused by the subcu-
taneous injection of 1 mg. of heat-killed bacilli in 1 cc. of light
mineral oil).
In view of these findings, which might appear to contradict
each other, certain facts must be recognized. One of these is the
obvious factor that the pathogenicity of even highly virulent human
or bovine tubercle bacilli is materially reduced by intracutaneous
as contrasted with subcutaneous or other internal infection. This
retarding influence, due to the route of infection, permits the inter-
play of factors which only become strikingly evident when much
smaller infecting amounts are used subcutaneously. It is thus that
specific tuberculo-immunity, which requires at least from 2 weeks to
2 months to develop fully, depending on the amount of bacilli
present initially or at a certain time, may play a decisive part in the
final results. Likewise, the specific tuberculo-bacillary and tuber-
culin allergy, recognized from these observations as two separate
reactions, the latter, the tuberculin allergy, probably not playing a
practical part in thediseasetuberculosis, maygive rise experimentally
to a reaction which may alter the picture through its effect upon the
bacilli locally introduced. It is this effect which is not clearly
understood and which may cause difficulty in interpretation. We
suggest the possibility of one of two, or both, reactions as the basis
for the effect noted. The very reaction itself may produce a dilu-
tion of the bacilli introduced and thus alter decidedly their
infectibility. As another possibility, injury to body cells pro-
duced by the reaction may make the injured cells a more fertile soil
for growth of the bacilli and the vascular reaction results in a more
ready spread of the bacilli internally without causing an evident
effect at the site itself. This would explain the lack of effect when
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tuberculin and bacilli are introduced into the skin coincidently, when
both dilution and reaction must come into play. However, when
injury has progressed, for 24 or 48 hours, to a maximum, dilution
is no longer feasible and injury is at a high level while vascularity
also is increased. These factors would tend both to propagate
virulent bacilli and to spread them along vascular channels.
Attempt to immunize against bacillary allergic hypersensitiveness
It is a well-known fact that progressive virulent infection
enhances specific tuberculo-allergic hypersensitiveness, both to a
reaction to tuberculin and to bacilli. Likewise, in previous experi-
ments it was found that repeated injections of even small amounts of
avirulent human tuberde bacilli into guinea-pigs decidedly enhanced
specific tuberculo-allergic hypersensitiveness to tuberculin and
bacilli. However, certain preliminary experiments seemed to show
that the intravenous use of heat-killed tubercle bacilli decreased the
hypersensitive reaction, and further experimentation was necessary
to explain this effect.
The following brief of this experiment, which will appear in
full elsewhere, discloses the fact that when specific immune and
tuberculo-allergic guinea-pigs (produced by the injection of viable
avirulent human tubercle bacilli) or specific allergic hypersensitive
guinea-pigs (produced by the injection of heat-killed bacilli in
mineral oil) are injected intravenously with heat-killed tubercle
bacilli in small well-tolerated amounts (0.1 mg.) at intervals of
5 days for 11 injections, the initial injections beginning with
vaccination, there appears to be a retardation in the development
of the allergic hypersensitive response to the intracutaneous injec-
tion of viable human bacilli. This is true despite the facts that
the animals appear normal generally and have gained weight
equally to normal controls fed in the same way. However, on
postmortem, these animals disclose a splenomegaly, due to the dead
bacilli introduced into the blood, and which may serve to explain
the diminished reaction, since similar animals, both specific immune
and specific allergic, given like repeated subcutaneous injections of
dead tubercle bacilli do not disdose this retarding effect on the
bacillo-allergic hypersensitive skin reaction resulting from the intra-
cutaneous injection of viable tubercle bacilli. On the other hand,
a definite accentuation of the allergic hypersensitive skin response
to viable tubercle bacilli occurred in specific immune and allergic
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guinea-pigs and in specific allergic guinea-pigs which were given
repeated injections of either viable avirulent human tubercle bacilli
or dead tuberde bacilli in mineral oil. The latter two prepara-
tions contained specific allergic sensitizing antigens in ample amounts
as compared with the paucity of such antigens in heat-killed tuberde
bacilli.
Summary and concluos
1. As a result of exact quantitative evaluation of the effects of
tuberculin treatment or desensitization in infected guinea-pigs, it
was found that both beneficial and detrimental effects or no appre-
ciable effect may be noted from the use of tuberculin in tuberculosis.
These findings explain the apparent incongruous results of observers
in the past, some finding in tuberculin a detrimental agent and
others noting beneficial or therapeutic effects. However, tuber-
culin, apparently not anatural product in the animal economy, exerts
no effect upon the tuberculous involvement unless acting indirectly
as an artificial toxic agent or in exaggerated, not naturally occurring,
experimental conditions. The anatomical tuberculous involvement
and its coincident allergic hypersensitiveness in the tuberculous
animal play a decsive part in the results obtained from tuberculin
treatment as measured in the duration of life of the animals in an
experiment. In man, the use of tuberculin therapy is not warranted
by any evidence available at present from animal experiments.
2. Although the coincdent injection of tuberculin with tuberde
bacilli intracutaneously in an allergic hypersensitive reacting animal
exerts no appreciable influence upon the metastatic tuberculosis,
resulting from virulent infection in specific immune or specific tuber-
culo-allergic guinea-pigs, the intracutaneous injection of the virulent
bacilli into a tuberculin site, which has been established for from 24
to 48 hours, results in an extension of the internal tuberculosis from
the local site (as previously noted by Allen Krause).
3. Tuberculin immunization (or desensitization) of specific
immune (vaccinated with viable avirulent tuberde bacilli) or spec-
fic tuberculo-allergic hypersensitive (caused by heat-killed bacilli in
mineral oil) guinea-pigs exerts no appreciable effect upon the result-
ing tuberculosis following the intracutaneous injection of virulent
human tubercle bacilli. Though the tuberculin immunized (or
desensitized) specific immune and allergic or specific tuberculo-
allergic hypersensitive guinea-pigs fail to react to tuberculin intra-
389390 YALE JOURNAL OF BIOLOGY AND MEDICINE
cutaneously and are protected against the lethal general effects of
tuberculin, they still react without appreciable retardation to viable
tuberde bacilli, indicating the persistence of the bacillary tuberculo-
allergic hypersensitiveness with the abolition of the tuberculin aller-
gichypersensitiveness. This phenomenon defines two separate types
of tuberculo-allergic hypersensitiveness: (a) that elicited by tuber-
culin, which seems to be of no practical importance in tuberculosis as
it occurs naturally, and (b) that elicited by viable tuberde bacilli and
which naturally assumes practical importance in the disease. These
experiments clarify the reasoning of investigators in the past who
assumed that tuberculo-allergy and tuberculo-immunity were synon-
ymous or that they represented closely related phenomena. These
deductions were not correct, however, since they were drawn from
the use of tuberculin as the test agent for allergy; and though it
must be admitted that bacillary tuberculo-allergy and specific tuber-
culo-immunity have not been separated as yet, this problem can
now be approached more intelligently. The use of dead or viable
tuberde bacilli in preliminary attempts to immunize (or desensitize)
for the purpose of treatment has not proved successful.
REFERENCES
1 Birkhaug, Konrad: Iathergic immunity in experimental tuberculosis. Chr.
Michelsen's Institutt for Videnskapog Andsfrihet, Beretninger X, 3.
Bergen, March, 1940. A. S. John Griegs Boktrykkeri.
2 Corper, H. J.: Historic album of specific immunity in tuberculosis. Rocky
Mountain Med. J., 1939, 1-14, (Supplement, 36).
3 Corper, H. J.: Analysis of the tubercle bacillus and its natural products by
immune, allergic, and anaphylactic tests. J. Infect. Dis., 1940, 66, 23-29.
4 Corper, H. J., and Cohn, M. L.: The effects of tuberculoprotein-A Quantita-
tive Study. J. Am. Med. Asso., 1939, 112, 403-8.
5 Corper, H. J., and Cohn, M. L.: Intoxication in tuberculosis. Am. Rev.
Tuberc., 1940, 41, 71-86.
6 Corper, H. J., and Cohn, M. L.: Two separate specific immune phenomena
in tuberculosis: A concrete demonstration. Am. Rev. Tuberc., 1942,
45, 200-11.
7 Corper, H. J., and Cohn, M. L.: Life expectancy of infected immune guinea
pigs and persistency of specific tuberculosis immunity. Bull. Am. Acad.
Tuberc. Physicians, 1940, 4, 158-67.
8 Corper, H. J., and Cohn, M. L.: The effect of paraffin hydrocarbons on
tuberculo-allergy and tuberculo-immunity produced by tubercle bacilli.
Am. J. Clin. Path., 1942, 12, 73-84.
9 Corper, H. J., Cohn, M. L., and Bower, C.: A study of the growth of human
tubercle bacilli on a nonprotein synthetic medium. J. Lab. & Clin. Med.,
1940, 25, 981-89.ALLERGY AND IMMUNITY IN TUBERCULOSIS 391
10 Corper, H. J., Cohn, M. L., and Damerow, A. P.: Studies on the behavior of
tubercle bacilli within the body. I to V. Am. Rev. Tuberc., 1936, 33,
679; 694; 701; 709; 721.
11 Corper, H. J., Cohn, M. L., and Damerow, A. P.: Specific artificial immunity
in tuberculosis. Am. J. Clin. Path., 1937, 7, 360-75.
12 Corper, H. J., Cohn, M. L., and Damerow, A. P.: Relations between specific
immunity, allergy, and anaphylaxis in tuberculosis. Am. J. Clin. Path.,
1940, 10, 361-79.
13 Corper, H. J., Damerow, A. P., and Cohn, M. L.: Tuberculoprotein desensi-
tization and tuberculosis. Am. J. Clin. Path., 1941, 11, 463-79.
14 Corper, H. J., Damerow, A. P., Cohn, M. L., and Vidal, C. B.: Vaccination
against tuberculosis-A comparative study in man and animals. J. Infect.
Dis., 1936, 58, 158-64.
15 Krause, A. K., and Willis, H. S.: Studies on immunity to tuberculosis. The
results of virulent reinfection into tuberculin-reacting areas (skin) of
tuberculous guinea pigs. Am. Rev. Tuberc., 1920/21, 4, 563-75.
16 Pottenger, F. M.: Immunity in tuberculosis: Clinical considerations. Am. Rev.
Tuberc., 1942, 45, 651-59.Xi,flidat',l,¢.XII
.. i @ 1 g ffi % %;
,,,'t I E I [.s :;; w '': _1
a 2d'iys b iweek, c 2weeks d 4weeks e 81week
FIG. 1. The development of skin lesions (a to e) in a normal guinea-pig following the intra-
cutaneous injection, in duplicate and from top to bottom, of 0.001, 0.000,01, and 0.000,000,1 mg. of
virulent human tubercle bacilli. Organic tuberculosis (f) 61 days after the infection.
a=2 days: b=1 week, c=2 weeks: d=4 weeks; e=8 weeks
Note the slow initial development and the progressive t aatureof all skin lesions.
progressive nature of the lesions t^s compared with the control animal (Fig 1)
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FIG. 3. The development of skin lesions (a to e) in a specific tuberculo-allergic (produced by
dead bacilli in oii) hypersensitive guinea-pig. Intracutaneouts injectionis as in Fig. 1 but with the
virulent bacilli mixed with a 1:100 dilution of Seitz filtrate containing 0.000,7 mg. of tuberculo-
protein. Organic tuberculosis (f) 61 days after infection.
a=2 days; b= 1 week; c= 2 veeks; d=4 weeks; e=8 weeks
Note the local tuberculin reactions (faint gray shadows around sites) after the 2-day and 1-week
periods; also note the discrete splenic tuberculosis.
FIG. 4. The development of skin lesions (a to e) in a specific tuberculo-allergic (dead bacilli
in oil) hypersensitive guinea-pig. Virulenit bacilli, as in Fig. 1, were injected into reacting sites
48 hours after the intracutaneous injection of the filtrate (0.000,7 mg. of tuberculoprotein). Organic
tuberculosis (f) 61 days after infection.
a=2 days; b=1 week; c=2 weeks; d=4 weeks; e=8 weeks
Note the reaction sites to the filtrate given 4 days before (a) and the subsequent development
of the lesions (b-e). Note also the retardation of the skin lesions. The organic tuberculosis is
more generalized and niore progressive.*:@0~~~~~~~~~~~~~~~~~~~~~-- W11'0 a~~~~~~~~~~~~~~~~~~~~~~~
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FIG. 5. The development of skin lesions (a to e) in a specific immiune (produced by vaccination usith viable avirulent human tubercle bacilli) and tuberculo-allergic hypersenisitive guinea-pig. Viru-
lenit bacilli were injected as in Fig. 1.
a=2 days: b= 1 week; c=2 weeks; d=4 weeks; e=8 weeks
Note the bacillary reaction at sites of the larger amounts of bacilli in (a). and the marked retarda-
tion or absence of lesions at later periods. No internal tuberculosis was found (f) after 61 days.
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FIG. 6. The development of skin lesions (a to e) in a specific immune (produced as in Fig. 5) and tuberculo allergic hypersensitive guneapig Virulent bacilli (as in Fig. 1) were mixed with
filtrate and injected as in Fig. 3.
a days: b wek; cv weeks. d 4weeks; e weeks
Note the tuberculin reactions at all asites at 2 days (a) anid the marked retardation of all lesions
from 1 to 8 weeks (b to e) No internal tuberculosis was found (f) after 61 days.FIG. 7. The development of skin lesions (a to e) in a specific immune (produced as in Fig. 5)
and tuberculo-allergic hypersensitive guinea-pig. Virulent humran bacilli (dosage as above) were
intracutaneously injected into sites which. 24 hours earlier, had received intractutaneously 0.000,7 mg.
of tuberculoprotein.
a=2 days; h=1 week; c=2 weeks; d=4 weeks; e=8 weeks
Note in (a) the remnant of the tuberculiin reaction (after 3 days), and the m,arked retardation of
all skin lesions. There was definite evidence of splenic tuberculosis at 61 days, indicating a general
spread of the disease. Compare with the case of the specific immune guinea-pig (Fig. 5) and with
that where the virulent bacilli and tuberculin were injected coincidently (Fig. 6).
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FIG 8 The development of skin lesions (a to e) in a specific immule (produced as in Fig. 5)
and tuberculo-allergic hypersensitive guinea-pig. Injections of virulent bacilli and of tuberculopro-
tein as in Fig. 7, but with the interval 48 hours.
a=2 davs; b=1 week; c=2 weeks; d=4 weeks; e=8 weeks
Note the remaining tuberculin effect in (a) (4-day reaction). and the marked retardation of all
skin lesions. In (f) there is definite evidence of an accentuated splenic tuberculosis, 61 days after
the virulent infection.
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FIG. 9. Differentiation of tuberculin and bacillary allergic hypersensitiveness. In each pig the skin reaction to tuberculini
(0.000,7 mg. of tuberculoprotein) appears in the upper left quadrant; to viable virulent bacilli (0.01 mg.) in the lower right
quadrant. a, b, and c in each case show the reactions to intracutaneous tuberculin at 3, 5, and 13 days, and to virulent
bacilli at 1, 3. and 11 days. The 5 guinea-pigs were: la-b-c=normal control; 2a-b-c=specific immune (vaccinated witll
viable avirulent bacilli) and tuberculo-allergic; 3a-b-c, like 2a-b-c except that the pig was desensitized (beginning with
vacciniation the pig received every 5th day for 7 injections 0.07 mg. of tuberculin intravenously); 4a-b-c=tuberculo-allergic
(made bacillo- and tuberculin-allergic by subcutaneous injection of dead bacilli in mineral oil); 5a-b-c, like 4a-b-c, but
desensitized like 3a-b-c.
Note the absence of skin reactions, for the 1st week in the control pig (1), and the rapidly developing (lst day)
reaction to viable bacilli in all animals whether desensitized or not and even in the absence of a tuberculin reaction in
desenisitized pigs (3a-b-c and 5a-b-c). The desensitized pigs (2a-b-c and 4a-b-c) show a definite reaction where vaccinated
with viable bacilli (2a-b-c) and a marked reaction with necrosis in the case of the specific allergic hypersensitive animal
(4a-b-c)FIG. 10. The effect of the local allergic hypersensitive reaction on the spread of tubercle bacilli
from the site.
a=control guinea-pig, 53 days after a single intracutaneous injection of 0.01 mg. of virulent
human tubercle bacilli.
b=absence of tuberculosis in a specific allergic (produced by dead bacilli in oil) pig, 53 days after
infection.
c=specific allergic tuberculin desensitized pig; absence of tuberculosis. The light areas in the
lungs are non-tuberculous artefacts.
d=specific allergic pig; coincident intracutaneous injection of tuberculin and virulent bacilli; no
internal tuberculosis.
e=specific allergic pig; bacilli injected intracutaneously into a 24-hour reacting tuberculin site;
splenic tuberculosis.
f=like e. except bacilli were injected into a 48-hour reacting site.
FIG. 11. The effect of specific immunity and tuberculo-allergy on the general spread of virulent
tubercle bacilli.
a=internal tuberculosis in a control guinea-pig (Fig. 10 a).
b=specific immune (vaccinated with viable avirtilent human bacilli) pig, 53 days after intracu-
taneous infection; no internal tuberculosis.
c=specific immune and tuberculin desensitized pig; 53 days; no internal tuberculosis. The light
areas in the lungs are non-ttuberculous artefacts.
d=specific immune and allergic pig; intracutaneous coincident injection of virulent bacilli and
tuberculin; no internal tuberculosis.
e=bacilli injected intracutaneously into 24-hour reacting tuberculin site; a few splenic tubercles.
The light spots on the lungs are non-tuberculous artefacts.
f=like e. except with a time interval of 48 hcurs.
l